Related Articles
Chemotherapy-Induced Nausea and Vomiting (CINV) – Guideline adherence for Low and Minimal Emetogenic RegimensICON supports appropriate and adequate anti-emesis for all patients receiving chemotherapy. This is crucial to improving the quality of life during chemotherapy treatment and has an impact on patient ... READ MORE
RMB Ventures and Bopa Moruo acquires majority stake in Icon Oncology Holdings.RMB Ventures (“RMBV”) and Bopa Moruo Private Equity (“Bopa Moruo”), alongside management, have acquired a majority stake in Icon Oncology Holdings (“Icon”) which is a leading provider of cancer ... READ MORE
Mediclinic Southern Africa, Icon Oncology and Cancercare open cancer treatment facility.Cape Town, 16 August: Mediclinic Southern Africa, Icon Oncology and Cancercare today celebrated a first in South Africa with the official opening of a new flagship cancer treatment centre based at ... READ MORE
Transforming oncology care in the Northern Cape ProvinceOn 21 November 2017, Equra Health PTY LTD and the Lenmed Royal Hospital and Heart Centre will take delivery of the Elekta Synergy Platform, a radiation therapy treatment system that will ... READ MORE
Icon Oncology is ready to close the gap in cancer care.Creating a viable solution for public and private partnerships. On World Cancer Day the Union for International Cancer Control (UUICC) and the global oncology community are calling on everyone to use ... READ MORE